Total Payments
$15,197
2024 Payments
$1,811
Companies
61
Transactions
781
Medicare Patients
9,889
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$13,047 (85.8%)
Travel$2,071 (13.6%)
Consulting$64.00 (0.4%)
Education$15.36 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,047 | 763 | 85.8% |
| Travel and Lodging | $2,071 | 11 | 13.6% |
| Consulting Fee | $64.00 | 1 | 0.4% |
| Education | $15.36 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,833 | 35 | $0 (2024) |
| Abbott Laboratories | $1,713 | 18 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $1,111 | 87 | $0 (2024) |
| Boston Scientific Corporation | $959.64 | 14 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $854.18 | 73 | $0 (2024) |
| Daiichi Sankyo Inc. | $763.00 | 60 | $0 (2019) |
| ABBVIE INC. | $706.87 | 48 | $0 (2024) |
| PFIZER INC. | $668.66 | 34 | $0 (2019) |
| Nevro Corp. | $571.89 | 10 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $534.88 | 32 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,811 | 49 | Medtronic, Inc. ($1,127) |
| 2023 | $1,026 | 60 | Medtronic, Inc. ($241.76) |
| 2022 | $2,405 | 85 | Abbott Laboratories ($1,251) |
| 2021 | $1,703 | 99 | GRT US Holding, Inc. ($271.87) |
| 2020 | $1,555 | 91 | Boston Scientific Corporation ($326.76) |
| 2019 | $1,827 | 95 | Nevro Corp. ($558.13) |
| 2018 | $1,975 | 130 | Daiichi Sankyo Inc. ($411.01) |
| 2017 | $2,895 | 172 | PFIZER INC. ($361.37) |
All Payment Transactions
781 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/25/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/12/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device), Zilretta | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Pain Management | ||||||
| 11/07/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/02/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.30 | General |
| Category: Opioid Analgesic | ||||||
| 09/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Gastroenterology | ||||||
| 08/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.78 | General |
| Category: Opioid Analgesic | ||||||
| 08/20/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.85 | General |
| Category: Opioid Analgesic | ||||||
| 07/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.81 | General |
| Category: Opioid Analgesic | ||||||
| 04/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/20/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $54.00 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 04/20/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 04/20/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 04/20/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Travel and Lodging | In-kind items and services | $19.21 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 04/20/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Travel and Lodging | In-kind items and services | $14.84 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,980 | 35,703 | $906,105 | $415,770 |
| 2022 | 25 | 2,079 | 38,381 | $847,994 | $472,747 |
| 2021 | 27 | 2,640 | 55,698 | $906,381 | $519,861 |
| 2020 | 30 | 3,190 | 77,870 | $1.1M | $574,253 |
Total Patients
9,889
Total Services
207,652
Medicare Billing
$2.0M
Procedure Codes
107
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 375 | 893 | $223,250 | $173,930 | 77.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 113 | 224 | $143,900 | $47,706 | 33.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 55 | 77 | $90,400 | $33,645 | 37.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 97 | 189 | $89,775 | $33,574 | 37.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 64 | 118 | $56,050 | $20,693 | 36.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 54 | 79 | $45,400 | $18,594 | 41.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 119 | 119 | $35,700 | $12,246 | 34.3% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 21 | 28 | $32,000 | $12,148 | 38.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 32 | 51 | $26,475 | $9,383 | 35.4% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 19 | 28 | $15,600 | $7,038 | 45.1% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 51 | 85 | $21,250 | $6,867 | 32.3% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 18 | 29 | $17,980 | $5,892 | 32.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 83 | 84 | $10,080 | $5,008 | 49.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 31 | 49 | $14,050 | $4,750 | 33.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 18 | 35 | $13,475 | $4,744 | 35.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 82 | 116 | $9,280 | $4,005 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 44 | $11,000 | $3,899 | 35.4% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 25 | 31 | $6,200 | $3,713 | 59.9% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 18 | 29 | $7,800 | $3,064 | 39.3% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 242 | 23,550 | $23,550 | $2,731 | 11.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $2,400 | $1,002 | 41.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 324 | 7,530 | $7,530 | $712.62 | 9.5% |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | Office | 2023 | 65 | 2,262 | $2,460 | $264.05 | 10.7% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Office | 2023 | 16 | 21 | $420.00 | $154.40 | 36.8% |
| J3010 | Injection, fentanyl citrate, 0.1 mg | Office | 2023 | 12 | 16 | $80.00 | $8.07 | 10.1% |
About Dr. Lam Nguyen, DO
Dr. Lam Nguyen, DO is a Pain Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1902082258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lam Nguyen, DO has received a total of $15,197 in payments from pharmaceutical and medical device companies, with $1,811 received in 2024. These payments were reported across 781 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($13,047).
As a Medicare-enrolled provider, Nguyen has provided services to 9,889 Medicare beneficiaries, totaling 207,652 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Tulsa, OK
- Active Since 01/17/2008
- Last Updated 02/23/2022
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1902082258
Products in Payments
- PROCLAIM (Device) $1,251
- KYPHON EXPRESS II KYPHOPAK TRAY (Device) $1,094
- RELISTOR (Drug) $735.57
- BOTOX (Biological) $658.91
- GENERAL - PAIN MANAGEMENT (Device) $655.29
- XTAMPZA (Drug) $593.32
- Senza Spinal Cord Stimulation System (Device) $558.13
- Morphabond ER (Drug) $548.27
- LYRICA (Drug) $505.01
- Horizant (Drug) $491.16
- AIMOVIG (Biological) $469.82
- Qutenza (Drug) $455.06
- Excelsius Robotics System (Device) $352.00
- Movantik (Drug) $331.46
- INTELLIS ADAPTIVESTIM (Device) $316.69
- UBRELVY (Drug) $287.49
- Xtampza ER (Drug) $229.82
- RELISTOR ORAL (Drug) $225.27
- Belbuca (Drug) $222.16
- Amitiza (Drug) $220.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Tulsa
Dr. Daniel Morris, Do, DO
Pain Medicine — Payments: $71,391
Pain Medicine $71,391
Dr. Traci White, M.d, M.D
Pain Medicine — Payments: $20,568
Pain Medicine $20,568
Brian Torgerson, M.d, M.D
Pain Medicine — Payments: $15,230
Pain Medicine $15,230
Dr. Jayen Patel, Md, MD
Pain Medicine — Payments: $14,399
Pain Medicine $14,399
Dr. Adam Wallace, M.d, M.D
Pain Medicine — Payments: $10,960
Pain Medicine $10,960
Kenneth Reed, Md, MD
Pain Medicine — Payments: $10,938
Pain Medicine $10,938